| Dr Glenn David Mcdermott, MD | |
|
Madigan Army Medical Center, 9040 Reid St; Attn: Mchj-qcr, Tacoma, WA 98431-0001 | |
| (253) 968-2252 | |
| (253) 968-3278 |
| Full Name | Dr Glenn David Mcdermott |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | Madigan Army Medical Center, Tacoma, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255309449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | 182618-1205 (Utah) | Primary |
| 2083X0100X | Preventive Medicine - Occupational Medicine | 182618-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn David Mcdermott, MD Madigan Army Medical Center, 9040 Reid St; Attn: Mchj-qcr, Tacoma, WA 98431-0001 Ph: (253) 968-2252 | Dr Glenn David Mcdermott, MD Madigan Army Medical Center, 9040 Reid St; Attn: Mchj-qcr, Tacoma, WA 98431-0001 Ph: (253) 968-2252 |
News Archive
The world's third rectal microbicide trial launched in Pittsburgh, Pennsylvania today, with sites preparing to open in Boston, Massachusetts, and Birmingham, Alabama soon. Scientists will test the rectal safety and acceptability of tenofovir gel, a microbicide developed for vaginal use that has shown promise for preventing HIV through vaginal intercourse. Depending on the outcome of this new study, tenofovir gel could be further evaluated to determine if it can reduce the risk of HIV among both men and women who engage in receptive anal intercourse.
A closer alliance between computational and experimental researchers is needed to make progress towards one of biology's most challenging goals, understanding how epigenetic marks contribute to regulation of gene expression.
MedImmune today announced an in-licensing agreement with Amgen for a novel monoclonal antibody targeting the IL-1 pathway. The antibody, AMG 108, a fully human monoclonal antibody to the IL-1 receptor, has been studied in multiple phase 1 and phase 2 clinical trials and will now be explored by MedImmune for its potential against certain inflammatory diseases.
We are what we eat. However, little is known on how a specific dietary regime can impact the life of the elderly. Now, researchers from an EU funded project called NU-AGE are investigating the effects of the Mediterranean diet on older people. Their aim is to get clues on how to counteract physical and cognitive decline through diet changes.
A newly accessible vaccine against Japanese encephalitis (JE) is going to make the protection of more children in developing countries easier. The vaccine, manufactured in China, only needs to be given in one dose, it can be used for infants, and it is less expensive than other Japanese encephalitis vaccines.
› Verified 4 days ago
Laura R. Kaufman, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 9505 S Steele St, Tacoma, WA 98444 Phone: 253-597-6800 | |
Dr. Kristen Marie Lovio, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-4986 Fax: 253-968-5903 | |
Dr. Bradley Clark Gardiner, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9040 Fitzsimmons Dr, Mchj-pv- Department Of Preventive Medicine, Tacoma, WA 98431 Phone: 253-426-5082 | |
Nathan Teague, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Dept Of Preventive Medicine, Bldg 9920 B East Hayes St., Tacoma, WA 98431 Phone: 253-968-4487 | |
Dr. Eric Brendan Smith, DO, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 Fax: 253-596-3301 | |
Dr. Kristin Elise Erickson, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave Medical Evaluation Board, Tacoma, WA 98431 Phone: 253-968-4479 |